Skip to main content

BRS5 — Gut-Brain Axis & Enteric Nervous System

BRS5-1-1 - Gut Barrier / Tight Junction Integrity​

1. Mission & Overview​

Mission​

Maintain epithelial tight junction integrity and selective permeability at the gut lining.

Intervention Dominance: Diet-Supported — Dietary Requirements

Overview​

The gut lining is a selective gate. Tight junctions, the seals between its cells, control which materials pass between them. Maintaining that selectivity helps protect the body while allowing normal exchange. Butyrate, cellular zinc and retinoid signalling affect epithelial functions in experimental models; glutamine has a condition-specific human permeability result. These findings identify different biological routes rather than a universal gut-repair supplement. [8]

  • Benefits: Selective permeability helps limit inappropriate passage across the gut lining; symptom benefits from supplementation are specific to the populations studied.
  • Implementation Notes: Fermentable substrates can supply microbial butyrate. Nutrient adequacy differs from extra-intake benefit; the glutamine trial concerned postinfectious diarrhoea-predominant IBS with confirmed hyperpermeability.
  • Biological Relevance: This PM concerns epithelial junction regulation. Mucus-specific microbial effects belong to PM3 and bioactive endotoxin containment to PM2. Lower electrical resistance may reflect selective ion permeability rather than unrestricted leakage.

2. Primary Biological Effects​

↑ tight-junction strength; ↓ permeability

3. Intervention Levers​

4. Mechanistic Basis​

Summary​

Cellular zinc supports junction-protein maintenance; retinoic acid influences epithelial differentiation and selective permeability. [8]

Biological process​

The zinc result supports a bounded cellular requirement. Retinoid biology cannot be simplified to lower permeability in every context. [8]

Mechanism Boundary​

This PM concerns epithelial junction regulation. Mucus-specific microbial effects belong to PM3 and bioactive endotoxin containment to PM2. Lower electrical resistance may reflect selective ion permeability rather than unrestricted leakage.

Integration​

This PM contributes its specific process to its parent FM. Shared inputs do not merge distinct jobs or prove an integrated clinical outcome.

Scientific Hypotheses​

Hypothesis-1 — Resistant Starch–Derived Butyrate and Tight-Junction Regulation Unestablished

Scientific hypothesis. Scientific admission is required before any proposed mechanism relationship can be approved, including when a hypothesis is marked Supported.

Proposition: Dietary resistant starch may regulate epithelial paracellular tight-junction function through microbial butyrate production and local exposure.

Proposed direction: BRS5-FM2-PM5 → BRS5-FM1-PM1

Rationale: Selected resistant-starch preparations support microbial butyrate production, and direct butyrate exposure can influence epithelial junction assembly. These separate observations motivate testing the joined dietary pathway; they do not establish it. The proposed five-link chain is: (1) dietary resistant-starch substrate reaches a capable microbial community; (2) utilisation and cross-feeding generate a context-dependent butyrate pool; (3) luminal butyrate becomes available to and is taken up by the epithelium; (4) cellular butyrate exposure engages pathways such as AMPK-related tight-junction assembly; (5) local engagement would produce a demonstrable paracellular tight-junction functional effect in the relevant host context. Evidence for separate links does not establish the complete chain. Moreau’s increased uptake followed healing; Peng’s cellular mechanism and the bounded human null/transcellular results must not be joined into an established dietary effect.

Supporting Findings

None identified as directly testing this proposition.

Contradictory or null Findings

None identified as directly testing this proposition.

Contextual Findings
  • BRS5-FM2-PM5 / PM5-F1 — Supports community- and formulation-dependent upstream fermentation, not a downstream tight-junction mechanism.
  • BRS5-FM1-PM1 / PM1-F2 — Butyrate-exposed epithelial models inform plausibility, not dietary resistant-starch mediation.
Source evidence and its role
  • Peng et al. (2009) (contextual) — Direct butyrate exposure supports AMPK-related junction assembly in Caco-2 monolayers. Purified exposure and cell model; not resistant-starch-derived epithelial exposure.
  • Moreau et al. (2004) (contextual) — In RS3-fed colitic rats, increased mucosal butyrate utilisation followed healing. Infused labelled butyrate uptake was not tracing starch carbon. Histological healing and substrate use do not establish paracellular tight-junction mediation.
  • Acute human colonic biopsy experiment (2020) (contradictory_or_null) — Acute 5 or 25 mM butyrate pretreatment did not prevent induced hyperpermeability ex vivo. Chemical injury and acute exposure; not a universal refutation of dietary or chronic effects.
  • Controlled potato/bagel dietary trial (2022) (contradictory_or_null) — The tested potato diet lowered small-intestinal permeability indices but not the colonic probe; it did not establish butyrate-mediated tight-junction regulation. Metabolic syndrome, short dietary periods and surrogate permeability measures; formulation effects and alternative pathways remain.
  • Scharf et al. (2025) (contextual) — Direct 100 mmol/L colonic butyrate perfusion for 90 minutes reduced induced transcellular hyperpermeability in IBS biopsies compared with pre-exposure. Transcellular outcome is not demonstrated paracellular tight-junction regulation. Direct perfusion is not dietary delivery and does not establish the resistant-starch pathway.

References to the same study or cohort are not independent evidence. Finding scores are not inherited.

Principal limitations
  • No joined dietary resistant-starch → butyrate → paracellular tight-junction mechanism has been established by the evidence reviewed here. This is a bounded assessment, not a claim that no such study exists anywhere.
  • Starch preparation, microbial degraders/cross-feeding, regional exposure and host state affect the pathway.
  • Faecal butyrate is not production flux or epithelial exposure; transcripts, electrical resistance, histology and paracellular marker flux are distinct endpoints.
  • Do not collapse human transcellular protection or small-intestinal permeability improvement into a colonic paracellular tight-junction result.
Alternative or interacting explanations
  • Other fermentation products, microbial shifts, altered bile acids, immune effects or nonfermentation food components may mediate a barrier result.
  • Mucosal healing may increase butyrate uptake rather than be caused by it.
Evidence required
  • A defined dietary preparation linked to local butyrate exposure and appropriate paracellular/junction endpoints, with credible causal mediation and microbial/host context addressed.
  • Starch-carbon tracing is one useful approach, not a mandatory exclusive admission criterion; perturbation, rescue and convergent mediation evidence may also be informative.
  • Separate paracellular from transcellular effects and measured exposure from inferred metabolite availability.
Historical provenance
  • Preparation history (2026-10-24): Prepared for approval after independent review on 2026-10-24; not implemented on the canonical PM page.
  • Preparation history (2026-10-24): Cursor report named PM1-H1 but explicitly said the page record was not written. The fetched main branch and inspected local PM1 copies have no such record.
  • Preparation history (2026-10-24): No admission, causal graph edge, Dietary Confidence assessment, food relationship or manuscript row is created by this proposal.
  • User approved canonical implementation on 2026-10-24, with status Unestablished and no dietary admission, confidence assessment, causal extraction or manuscript eligibility. The approved title was applied without changing the prepared source assessments.

Reviewed: 2026-10-24. PM1-H1

4.1 Scientific Findings (12)​

Scientific Findings and their source assessments are available in Evidence & Audit.

5. BRS Pathways and Connections​

5.1 BRS Pathways​

No newly adjudicated pathway is established by this assessment.

5.2 Cross-BRS Mechanism Relationships​

Existing connected mechanisms remain candidates in the review history; no new downstream admission is inferred.

5.3 Local BRS Mechanism Relationships​

7. Phenome Connections​

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

No direct functional outcome relationship currently mapped.

Stage 2A/2B dietary-target assessment — 23 October 2026

ENRICHED. Selective epithelial permeability and tight-junction maintenance.

Resolve the previously Unset glutamine supply atom to Yes under Type A Capacity, with cell junction evidence and the existing clinical oral exposure separately documented. Preserve its original atom in the baseline/history. Food-specific glutamine composition remains unresolved: combined Glx is not glutamine. Flag inherited van Trijp/Pascale source-attribution concerns without rewriting old Findings or admissions.

New implementation: 1 dietary-input admissions (1 completed Unset candidates), 0 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.

Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.

8. References​